KP

Keshav Patel

Active Director Director DIN 08286316
DIN 08286316 First appointment Nov 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value •••• Premium profile

About Keshav Patel

Data last updated:

Keshav Patel is a Director at Selecsai Pharmaceutical Private Limited (since 2018). The company operates in Pharma. Selecsai Pharmaceutical Private Limited reported revenue of ₹33,440 (FY 2025).

DIN 08286316
Primary Designation Director
Industry Pharma
First Appointment 26 Nov 2018
Oldest Company Age 7 yrs
Largest company Selecsai Pharmaceutical Private Limited · ₹33,440 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Nov 20182018₹33,440 (FY 2025)Active

Board colleagues of Keshav Patel

NameDINCompanyDesignation
Krishna Gopal Patel08286317Selecsai Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Selecsai Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Keshav Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Keshav Patel

Keshav Patel currently holds 1 directorship: Selecsai Pharmaceutical Private Limited (Director, since 26 Nov 2018, revenue ₹33,440 (FY 2025)).

Keshav Patel was first appointed on 26 Nov 2018 as Director at Selecsai Pharmaceutical Private Limited.

The current boards of Keshav Patel's companies include Krishna Gopal Patel (Selecsai Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available